Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

Overview of attention for article published in Radiation Oncology, November 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 7,951 followers.

RT @JoaquinJCabrera: Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5…

RT @JoaquinJCabrera: Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5…

RT @JoaquinJCabrera: Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5…

RT @JoaquinJCabrera: Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.